Related Experiment Video
Updated: Jul 9, 2026
08:36
The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
Published on: April 19, 2024
Meta-analysis of continuous outcomes combining individual patient data and aggregate data
Richard D Riley1, Paul C Lambert, Jan A Staessen
1Centre for Medical Statistics and Health Evaluation, Faculty of Medicine, University of Liverpool, Shelley's Cottage, Brownlow Street, Liverpool, U.K. richard.riley@liv.ac.uk
Statistics in Medicine
|December 12, 2007
Summary
Combining individual patient data (IPD) and aggregate data (AD) in meta-analysis enhances evidence synthesis. New statistical methods allow for the integration of both IPD and AD, improving the utilization of all available clinical trial information.
Area of Science:
- Biostatistics
- Clinical Epidemiology
- Health Research Synthesis
Background:
- Meta-analysis of individual patient data (IPD) is the gold standard for evidence synthesis.
- Aggregate data (AD) meta-analysis is used when IPD is unavailable, potentially leading to incomplete evidence utilization.
Purpose of the Study:
- To develop and assess statistical methods for combining IPD and AD in meta-analysis of continuous outcomes.
- To improve the comprehensive synthesis of evidence from randomized controlled trials.
Main Methods:
- Development of one-step and two-step statistical approaches for IPD and AD meta-analysis.
- Utilizing dummy variables in a one-step approach to differentiate IPD and AD trials and constrain parameter estimation.
- Developing models to separate within-trial and across-trials treatment-covariate interactions to avoid ecological bias.
Main Results:
- The one-step approach provides a flexible framework for integrating patient-level and trial-level parameters.
- Models effectively separate within-trial and across-trials treatment-covariate interactions, addressing confounding.
- Demonstrated benefits of utilizing AD alongside IPD in a hypertension meta-analysis.
Conclusions:
- Statistical methods for combining IPD and AD are crucial for maximizing evidence from clinical studies.
- The developed methods offer a robust framework for meta-analysis involving mixed data types.
- Integrating AD with IPD enhances the accuracy and completeness of meta-analytic findings.
Related Concept Videos
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:24Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:23Mechanistic Models: Compartment Models in Individual and Population Analysis
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...